?Baloxavir Intermediate (CAS 1370250-39-7)?
Google Keywords: Baloxavir Intermediate, CAS 1370250-39-7, Antiviral API Synthesis, Influenza Drug Production, GMP Pharmaceutical Intermediates

?? ?Product Overview?

?Baloxavir Intermediate? (CAS 1370250-39-7) is a high-purity chemical intermediate essential for synthesizing ?Baloxavir Marboxil?, a groundbreaking antiviral API used to treat influenza A and B infections. This intermediate enables precise and scalable manufacturing of the drug, ensuring compliance with stringent pharmaceutical quality standards.

1. ?Primary Function?: Facilitates efficient synthesis of Baloxavir Marboxil with controlled impurity profiles.

2. ?Applications?: Antiviral drug production, clinical trial material preparation, and generic API development.

? ?Key Advantages?

?? ?Ultra-High Purity? | ≥99.0% (HPLC/GC verified) | Residual solvents <50 ppm.
?? ?Regulatory Compliance? | Aligns with ICH Q11 guidelines and GMP requirements for intermediates.
?? ?Scalability? | Validated for consistent performance in commercial-scale API manufacturing.

?? ?Applications?

• ?Influenza Therapeutics?: Critical for synthesizing Baloxavir Marboxil, a single-dose oral antiviral.

• ?Clinical Development?: Supports formulation studies and stability testing for regulatory submissions.

• ?Generic Drug Manufacturing?: Enables cost-effective production post-patent expiration.

?? ?Quality Assurance?

• ?Testing Methods?: HPLC, GC, NMR, and LC-MS for identity, purity, and impurity analysis.

• ?Standards?: Complies with USP <1086>, EP 10.0, and ISO 9001:2015 certified processes.

?? ?Market Trends?

The global ?antiviral drug market? is projected to reach ?$78.5 billion by 2030? (CAGR 4.3%), driven by rising influenza outbreaks and demand for novel therapies like Baloxavir. This intermediate addresses the growing need for efficient, scalable API production in pandemic preparedness.

Drive innovation in antiviral drug development with Baloxavir Intermediate – precision, compliance, and scalability for global health solutions.